Alembic Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
13 Nov 2025
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dexlansoprazole Delayed-Release Capsules, 30mg and 60 mg.
Source:
BSE India